Evidence map›Paper›PMID 34632003›Full record

ArticleBone reports2021

Non-polar lipid from greenshell mussel (Perna canaliculus) inhibits osteoclast differentiation.

Parkpoom Siriarchavatana, Marlena C Kruger, Matthew R Miller, Hong Tian, Frances M Wolber

Open access · goldAbstract read
In one paragraph

Article in Bone reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Parkpoom SiriarchavatanaSchool of Food and Advanced Technology, Massey University, Palmerston North 4442, New Zealand.
Marlena C KrugerSchool of Health Sciences, Massey University, Palmerston North 4442, New Zealand.
Matthew R MillerCawthron Institute, Nelson 7042, New Zealand.
Hong TianSanford Ltd., Auckland 1010, New Zealand.
Frances M WolberSchool of Food and Advanced Technology, Massey University, Palmerston North 4442, New Zealand.
Massey University · NZCawthron Institute · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The osteoclast-dependent bone resorption process is a crucial part of the bone regulatory system. The excessive function of osteoclasts can cause diseases of bone, joint, and other tissues such as osteoporosis and osteoarthritis. Greenshell mussel oil (GSM), a good source of long chain omega-3 polyunsaturated fatty acids (LCn-3PUFAs), was fractionated into total lipid, polar lipid, and non-polar lipid components and their anti-osteoclastogenic activity tested in RAW 264.7 cell cultures. Osteoclast differentiation process was achieved after 5 days of incubation with RANKL in 24-well culture plates. Introducing the non-polar lipid fraction into the culture caused a lack of cell differentiation, and a reduction in tartrate-resistant acid phosphatase (TRAP) activity and TRAP cell numbers in a dose-dependent manner (50% reduction at the concentration of 20 μg/mL, p < 0.001). Moreover, actin ring formation was significantly diminished by non-polar lipids at 10-20 μg/mL. The bone digestive enzymes released by osteoclasts into the pit formation were also compromised by downregulating gene expression of cathepsin K, carbonic anhydrase II (CA II), matrix metalloproteinase 9 (MMP-9), and nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1). This study revealed that the non-polar lipid fraction of GSM oil contains bioactive substances which possess potent anti-osteoclastogenic activity.

Indexed as

AA, Arachidonic acidALA, Alpha linolenic acidCAII, Carbonic anhydrase IIDHA, Docosahexaenoic acidDMSO, dimethyl sulfoxideDPA, Docosapentaenoic acidEPA, Eicosapentaenoic acidFFAR, Free fatty acid receptorGreenshell musselGSM, Greenshell musselLA, Linoleic acidLPS, LipopolysaccharideMMP-9, Matrix metalloproteinase 9MUFA, Monounsaturated fatty acidNFATc1, Nuclear factor of activated T-cells, cytoplasmic 1NF-κB, Nuclear factor κBOA, OsteoarthritisOmega 3 fatty acidOsteoarthritisOsteoclastsOsteoporosisPA, Palmitic acidPPAR, Peroxisome proliferator activated receptorPUFA, Polyunsaturated fatty acidRANKL, Receptor activator of nuclear factor κB ligandSFA, Saturated fatty acidTRAP, Tartrate-resistant acid phosphatase

Identifiers

PMID34632003
PMCPMC8493498
OpenAlexW3203807711

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.